Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03066843 · ClinicalTrials.gov registry record · NA
Photodynamic Therapy Incubation Times for Actinic Keratosis
A NA study of Actinic Keratoses, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03066843: Active NA study of Actinic Keratoses, sponsored by Northwestern University.
NCT03066843 is a NA study of Actinic Keratoses that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 60 participants, below the 93-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03066843, a NA study of Actinic Keratoses, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized clinical trial evaluating blue light 5-aminolevulinic acid (ALA) photodynamic therapy with different incubation times for the treatment of actinic keratosis. Subjects who are interested in participating, currently living in the Chicago metropolitan area, and meet inclusion and exclusion criteria will be enrolled in the study. Subjects will be randomized to either 1) zero time ALA incubation or 2) 1 hour ALA incubation. Demographic and health data will be collected prior to treatment initiation. Three visits will be conducted: screening, treatment, and follow up visit at 8 weeks. This study is a pilot study designed to determine feasibility of this procedure.
Primary Outcome
The number of AK lesions will be counted by a live, blinded assessor at baseline and at Week 8 follow-up visit.
Conditions Studied
Interventions
- DRUG ALA (5-aminolevulinic acid)
- DEVICE Blue light therapy
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine, Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT03066843 still lists
NCT03066843 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 93-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Actinic Keratoses appearing as the primary indexed condition, and to 2 interventions - of which ALA (5-aminolevulinic acid) is the first listed.
NCT03066843 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03066843 about?
NCT03066843 is a clinical study titled "Photodynamic Therapy Incubation Times for Actinic Keratosis". This is a randomized clinical trial evaluating blue light 5-aminolevulinic acid (ALA) photodynamic therapy with different incubation times for the treatment of actinic keratosis. Subjects who are interested in participating, currently living in the Chicago metropolitan area, and meet inclusion and ...
What is the current status of trial NCT03066843?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2017-03-01. Estimated completion is 2025-12.
What conditions does trial NCT03066843 study?
This clinical trial studies the following conditions: Actinic Keratoses.
What interventions are being tested in trial NCT03066843?
The interventions under investigation include: ALA (5-aminolevulinic acid) (DRUG), Blue light therapy (DEVICE).
Who is sponsoring clinical trial NCT03066843?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03066843 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Actinic Keratoses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03066843's enrollment target sits among peer trials
60 5th of 12 higher than 8 of 12 other Actinic Keratoses trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Actinic Keratoses trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
RECRUITING · NA
-
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
RECRUITING · NA
-
Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video
COMPLETED · NA
-
A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
COMPLETED · NA
-
A Photodynamic Therapy for Treatment of Actinic Keratoses
COMPLETED · NA
-
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI